Literature DB >> 29687673

Effectiveness of non-pharmacological measures for reducing pain and fear in children during venipuncture in the emergency department: a vibrating cold devices versus distraction.

Noelia García-Aracil1, Juan Diego Ramos-Pichardo2, María Elena Castejón-de la Encina1, Lourdes José-Alcaide1, Rocío Juliá-Sanchís3, Ángela Sanjuan-Quiles3.   

Abstract

OBJECTIVES: To assess the effectiveness of a physical method of managing pain and fear in children and anxiety in the accompanying adult during venous puncture in the emergency department.
MATERIAL AND METHODS: Quasi-experimental study of 3 groups: one group used a combination of directed distraction by means of a vibration device with ice pack, a second group received only distraction, and no strategy was used in the third.
RESULTS: Pain and adult anxiety were similar in the 2 groups in which a pain management strategy was applied. Pain and adult anxiety were greater when no strategy was adopted. We detected no differences in the level of the children's fear.
CONCLUSION: Directed distraction can be useful for managing pain in children and it reduces the anxiety experienced by accompanying adults. The use of a vibration device with ice does not add benefits. Fear is not reduced by any of these measures.

Entities:  

Keywords:  Children; Efectividad; Effectiveness; Fear, procedures; Manejo del dolor; Medidas no farmacológicos; Miedo al procedimiento; Niño; Pain Management; Physical modalities; Venopunción; Venous puncture

Mesh:

Year:  2018        PMID: 29687673

Source DB:  PubMed          Journal:  Emergencias        ISSN: 1137-6821            Impact factor:   3.881


  1 in total

1.  Comparison of music and vapocoolant spray in reducing the pain of venous cannulation in children age 6-12: a randomized clinical trial.

Authors:  Masoomeh Ghasemi; Poria Hoseinialiabadi; Fatemeh Yazdanpanah; Maryam Askaryzadeh Mahani; Leila Malekyan; Kazem Najafi; Mohammadreza Arab; Mansour Arab; Hadi Ranjbar
Journal:  BMC Pediatr       Date:  2022-04-29       Impact factor: 2.567

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.